ArticleFrontiers in nutrition2025
The protective effect of Saudi Arabian bee honey against excessive weight gain and obesity-related parameters in rats fed a high-fat diet.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Nutritional Composition, Glycemic Index, Antioxidant and Anti-Inflammatory Activities of Five Monofloral Honeys from Qassim, Saudi Arabia: A Component-Effect Relationship Study.Foods (Basel, Switzerland) · 2026Article
- Photocatalytic degradation of polyethylene films using green-synthesized ZnO and FeScientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This study aimed to investigate the anti-obesity, hepatic protective, and metabolic effects of Sidr and Talh honey, two Saudi honey, in rats fed a high-fat diet (HFD) and examined some possible mechanisms of their action. Methods: Adult rats were divided into eight groups ( Results and Discussion: Talh honey significantly reduced body weight, fat mass, and adiposity markers, including mesenteric, subcutaneous, and epididymal fat, compared to the HFD group. It also improved plasma glucose, insulin, HOMA-IR, HbA1C, leptin, triglycerides, cholesterol, LDL-c, and increased adiponectin. Sidr honey showed no effects on the majority of these factors, except it was able to lower glucose, HbA1C, and HOMA-IR, but was less effective than Talh honey. Both honeys reduced hepatic triglycerides and cholesterol, but Talh honey had superior effects on liver enzymes (ALT, AST, γ-GTT), inflammatory cytokines (TNF-α, IL-6), and oxidative stress markers (MDA, GSH, SOD). Talh honey also enhanced hepatic nuclear Nrf2 levels and AMPK signaling in the liver and white adipose tissue. These findings indicate that Talh honey exhibits more potent anti-obesity, hepatoprotective, antioxidant, and anti-inflammatory effects than Sidr honey, likely via modulation of AMPK and Nrf2 pathways.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.